⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TTRX News
Turn Therapeutics Inc. Common Stock
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44 th Annual J.P. Morgan Healthcare Conference
businesswire.com
TTRX
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
globenewswire.com
TTRX
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
globenewswire.com
TTRX
Turn Therapeutics CEO, Bradley Burnam, Speaks with Former Director of the Centers for Disease Control and Prevention Dr. Robert Redfield, M.D.
globenewswire.com
TTRX
Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine
globenewswire.com
TTRX
Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications
globenewswire.com
TTRX
Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline
globenewswire.com
TTRX